Volume 71, Issue 5, Pages (May 2017)

Slides:

Advertisements

Similar presentations

Volume 59, Issue 2, Pages (February 2011)

Advertisements

Volume 62, Issue 1, Pages (July 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

Testosterone Therapy in Men With Prostate Cancer

Volume 70, Issue 6, Pages (December 2016)

Volume 52, Issue 1, Pages (July 2007)

Volume 53, Issue 5, Pages (May 2008)

Volume 65, Issue 5, Pages (May 2014)

Volume 70, Issue 2, Pages (August 2016)

Volume 71, Issue 5, Pages (May 2017)

Prostate Cancer Epidemic in Sight?

Volume 52, Issue 4, Pages (October 2007)

Volume 72, Issue 5, Pages (November 2017)

Volume 63, Issue 1, Pages (January 2013)

Volume 59, Issue 2, Pages (February 2011)

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

Volume 68, Issue 5, Pages (November 2015)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Volume 67, Issue 2, Pages (February 2015)

Volume 68, Issue 5, Pages (November 2015)

Volume 54, Issue 4, Pages (October 2008)

Volume 61, Issue 4, Pages (April 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 68, Issue 3, Pages (September 2015)

Volume 67, Issue 3, Pages (March 2015)

Volume 56, Issue 2, Pages (August 2009)

Volume 64, Issue 5, Pages (November 2013)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 63, Issue 5, Pages (May 2013)

Volume 67, Issue 6, Pages (June 2015)

Volume 71, Issue 5, Pages (May 2017)

Volume 62, Issue 1, Pages (July 2012)

Volume 71, Issue 6, Pages (June 2017)

Volume 54, Issue 2, Pages (August 2008)

Volume 53, Issue 4, Pages (April 2008)

Volume 64, Issue 6, Pages (December 2013)

Volume 73, Issue 2, Pages (February 2018)

Prostate Cancer Epidemic in Sight?

Volume 53, Issue 2, Pages (February 2008)

Volume 64, Issue 4, Pages (October 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 2, Pages (August 2014)

Volume 62, Issue 4, Pages (October 2012)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Physical Activity and Survival After Prostate Cancer

Volume 53, Issue 1, Pages (January 2008)

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Volume 62, Issue 6, Pages (December 2012)

Volume 50, Issue 5, Pages (November 2006)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy Matthew Mossanen, Kenneth.

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Volume 74, Issue 6, Pages (December 2018)

Axel Heidenreich European Urology Supplements

Volume 74, Issue 6, Pages (December 2018)

Volume 54, Issue 3, Pages (September 2008)

Axel Heidenreich European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 71, Issue 5, Pages 750-759 (May 2017) Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes Michael S. Leapman, Janet E. Cowan, Jeffry Simko, Gray Roberge, Bradley A. Stohr, Peter R. Carroll, Matthew R. Cooperberg European Urology Volume 71, Issue 5, Pages 750-759 (May 2017) DOI: 10.1016/j.eururo.2016.11.032 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Kaplan-Meier survival plots and tables with numbers of events and numbers of patients still at risk at each time point for (A) prostate cancer–specific survival and (B) bone metastasis–free survival stratified by prognostic Gleason score category at biopsy. CE=cumulative events. European Urology 2017 71, 750-759DOI: (10.1016/j.eururo.2016.11.032) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 2 Kaplan-Meier survival plots and tables with numbers of events and numbers of patients still at risk at each time point for (A) prostate cancer–specific survival and (B) bone metastasis–free survival stratified by traditional extended Gleason categories. CE=cumulative events. European Urology 2017 71, 750-759DOI: (10.1016/j.eururo.2016.11.032) Copyright © 2016 European Association of Urology Terms and Conditions